Dow Up0.51% Nasdaq Up0.24%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.70 Up 0.17(1.09%) Nov 21, 4:00PM EST
|After Hours : 15.72 Up 0.02 (0.13%) Nov 21, 7:48PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 256   -   10,000   -  
Cost of Revenue154   -   -   -  
Gross Profit 102   -   10,000   -  
Operating Expenses
Research Development19,053  11,079  15,555  8,110  
Selling General and Administrative16,447  11,464  8,096  9,629  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (35,398) (22,543) (13,651) (17,739)
Income from Continuing Operations
Total Other Income/Expenses Net109  129  121  71  
Earnings Before Interest And Taxes(35,289)(22,414)(13,530)(17,668)
Interest Expense -   -   -   -  
Income Before Tax(35,289)(22,414)(13,530)(17,668)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(35,289)(22,414)(13,530)(17,668)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (35,289) (22,414) (13,530) (17,668)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (35,289) (22,414) (13,530) (17,668)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.